CIK 0001709941 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BioAge Labs, Inc.
Sign in to watch- Ticker
- BIOA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474721157
- Phone
- 510-806-1445
- Business address
- 5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-17 | Hemrajani Rekha Director | Grant or award · Stock Option (Right to Buy) | +28,497 | 28,497 | ||
| 2024-04-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +257,973 | 257,973 | ||
| 2024-04-17 | Morgen Eric Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +13,598 | 13,598 | ||
| 2024-03-26 | Davidson Michael H. Director | Grant or award · Stock Option (Right to Buy) | +33,986 | 33,986 |
Page 7 of 7 · 124 trades